Articoli di riviste sul tema "Fingolimod hydrochloride"
Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili
Vedi i top-21 articoli di riviste per l'attività di ricerca sul tema "Fingolimod hydrochloride".
Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.
Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.
Vedi gli articoli di riviste di molte aree scientifiche e compila una bibliografia corretta.
Kaduk, James A., Kai Zhong, Amy M. Gindhart e Thomas N. Blanton. "Crystal structure of fingolimod hydrochloride, C19H34ClNO2". Powder Diffraction 30, n. 3 (12 agosto 2015): 205–10. http://dx.doi.org/10.1017/s0885715615000317.
Swain, Jitendriya, Santosh R. Borkar, Indrapal Singh Aidhen e Ashok Kumar Mishra. "A molecular level understanding of interaction between FTY720 (Fingolimod hydrochloride) and DMPC multilamellar vesicles". RSC Adv. 4, n. 33 (2014): 17347–53. http://dx.doi.org/10.1039/c4ra02404d.
Ganhadeiro, Flaviane Maximino Bitencourt, Carla Resende Vaz Oliveira e Bruno Cezario Costa Reis. "O benefício do uso de fingolimode em pacientes portadores de Esclerose Múltipla". Revista Eletrônica Acervo Médico 23, n. 4 (15 aprile 2023): e12504. http://dx.doi.org/10.25248/reamed.e12504.2023.
Balasubramaniam, Sivaraman, Ganapathy Sankaran e Sneh Badle. "Perspective on FTY720, an Immunosuppressant". Synthesis 50, n. 05 (24 gennaio 2018): 968–83. http://dx.doi.org/10.1055/s-0036-1591877.
Hussar, Daniel A., e David E. Zimmerman. "New drugs: Dabigatran etexilate mesylate, fingolimod hydrochloride, and ulipristal acetate". Journal of the American Pharmacists Association 51, n. 1 (gennaio 2011): 122–26. http://dx.doi.org/10.1331/japha.2011.11506.
Vinigari, Krishna, Krishna Jonnada, Noorjahan Mohammed e Girija Mangatayaru Kotu. "An alternative efficient approach for the synthesis of Fingolimod hydrochloride". Synthetic Communications 49, n. 1 (2 gennaio 2019): 39–48. http://dx.doi.org/10.1080/00397911.2018.1536788.
Thomas, Katja, Undine Proschmann e Tjalf Ziemssen. "Fingolimod hydrochloride for the treatment of relapsing remitting multiple sclerosis". Expert Opinion on Pharmacotherapy 18, n. 15 (4 settembre 2017): 1649–60. http://dx.doi.org/10.1080/14656566.2017.1373093.
Ward, Melanie D., David E. Jones e Myla D. Goldman. "Overview and safety of fingolimod hydrochloride use in patients with multiple sclerosis". Expert Opinion on Drug Safety 13, n. 7 (16 giugno 2014): 989–98. http://dx.doi.org/10.1517/14740338.2014.920820.
Tamakuwala, Mayurkumar, Warren Ratna, Amit Joshi e Grazia Stagni. "Fingolimod hydrochloride gel shows promising therapeutic effects in a mouse model of atopic dermatitis". Journal of Pharmacy and Pharmacology 68, n. 10 (27 luglio 2016): 1268–77. http://dx.doi.org/10.1111/jphp.12588.
Suresh Kumar, Ramdoss, Hariram Balasubramanian, Kalyanaraman Lakshminarayanan, Srinivasu K. Mullapudi, Katkam Srinivas e Rajeswar Reddy Sagyam. "A systematic approach for reversed phase liquid chromatographic method development of fingolimod hydrochloride via design augmentation". Arabian Journal of Chemistry 12, n. 8 (dicembre 2019): 3289–301. http://dx.doi.org/10.1016/j.arabjc.2015.08.012.
Wang, Jian-Rong, Sha Li, Bingqing Zhu e Xuefeng Mei. "Insight into the conformational polymorph transformation of a block-buster multiple sclerosis drug fingolimod hydrochloride (FTY 720)". Journal of Pharmaceutical and Biomedical Analysis 109 (maggio 2015): 45–51. http://dx.doi.org/10.1016/j.jpba.2015.02.018.
Chiba, Kenji, e Narihiko Yoshii. "Pharmacological properties and clinical efficacy of fingolimod hydrochloride (Imusera^|^reg;/Gilenya^|^reg;) for the treatment of multiple sclerosis". Folia Pharmacologica Japonica 139, n. 6 (2012): 265–74. http://dx.doi.org/10.1254/fpj.139.265.
Swain, Jitendriya, Monalisa Mohapatra, Santosh R. Borkar, Indrapal Singh Aidhen e Ashok Kumar Mishra. "Study of aqueous phase aggregation of FTY720 (fingolimod hydrochloride) and its effect on DMPC liposomes using fluorescent molecular probes". Physical Chemistry Chemical Physics 15, n. 41 (2013): 17962. http://dx.doi.org/10.1039/c3cp53148a.
Tamakuwala, M., e G. Stagni. "Fingolimod Hydrochloride Gel for Dermatological Applications: Optimization of Formulation Strength and Effect of Colloidal Oatmeal (Aveeno®) as Penetration Enhancer". AAPS PharmSciTech 17, n. 4 (29 settembre 2015): 907–14. http://dx.doi.org/10.1208/s12249-015-0415-9.
Takasaki, Teruaki, Kanako Hagihara, Ryosuke Satoh e Reiko Sugiura. "More than Just an Immunosuppressant: The Emerging Role of FTY720 as a Novel Inducer of ROS and Apoptosis". Oxidative Medicine and Cellular Longevity 2018 (28 marzo 2018): 1–13. http://dx.doi.org/10.1155/2018/4397159.
Rajan, N., e K. Anver Basha. "Rapid Determination of Fingolimod Hydrochloride-Related Substances and Degradation Products in API and Pharmaceutical Dosage Forms by Use of a Stability-Indicating UPLC Method". Chromatographia 77, n. 21-22 (15 ottobre 2014): 1545–52. http://dx.doi.org/10.1007/s10337-014-2751-4.
Ostroumova, O. D., M. S. Cherniaeva, D. I. Bakhteeva, N. A. Arablinskiy e D. A. Sychyov. "Some groups of drugs which use is associated with development of drug-induced atrial fibrillation". Medical alphabet 1, n. 11 (15 giugno 2021): 20–28. http://dx.doi.org/10.33667/2078-5631-2021-11-20-28.
Buylova, I. A., N. G. Sakhno, G. M. Bulgakova e O. V. Gunar. "ELIMINATION OF FALSE RESULTS OF MEDICINES MICROBIOLOGICAL TESTING". Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products 8, n. 3 (26 settembre 2018): 187–92. http://dx.doi.org/10.30895/1991-2919-2018-8-3-187-192.
"New drugs: Fingolimod hydrochloride". Australian Prescriber 34, n. 5 (1 ottobre 2011): 153–59. http://dx.doi.org/10.18773/austprescr.2011.081.
Hussain, Afzal, Ashfaq Hussain e Chandan Kumar Verma. "COVID-19 infection: A review of summarized Clinical trials study for the treatment". Coronaviruses 01 (25 settembre 2020). http://dx.doi.org/10.2174/2666796701999200925204309.
Ye, Min, Yongkang Gai, Hao Ji, Yaqun Jiang, Pengxin Qiao, Wenxia Wang, Yongxue Zhang, Xiaotian Xia e Xiaoli Lan. "A Novel Radioimmune 99mTc-Labeled Tracer for Imaging Sphingosine 1-Phosphate Receptor 1 in Tumor Xenografts: An In Vitro and In Vivo Study". Frontiers in Immunology 12 (18 agosto 2021). http://dx.doi.org/10.3389/fimmu.2021.660842.